浙江華遠(301535.SZ):目前公司相關產品並未在人形機器人領域得以量產應用
格隆匯5月27日丨浙江華遠(301535.SZ)在互動平臺表示,公司目前業務主要聚焦於汽車領域。作爲汽車零部件供應商,我們始終對新興科技領域的合作機會保持開放態度,公司也將持續關注相關行業技術發展趨勢,如:人形機器人領域應用的緊固件、傳感器基座及高精密機加工件與公司目前生產銷售的產品存在一定的技術同源性,相信依託我們多年的技術積累,未來我們華遠也會在衆多新興領域有所建樹、有所表現。但需要說明的是,任何具體合作都需要經過嚴格的技術適配驗證和商務流程,目前公司相關產品並未在人形機器人領域得以量產應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.